Skip to content

Is finasteride a DHT blocker? The science behind a popular hair loss medication

4 min read

Clinical studies have shown that finasteride can reduce serum dihydrotestosterone (DHT) levels by up to 70%. But how exactly does this mechanism work, and more importantly, is finasteride a DHT blocker?

Quick Summary

Finasteride is a 5-alpha reductase inhibitor that blocks the conversion of testosterone into dihydrotestosterone (DHT), a hormone linked to male pattern hair loss and prostate enlargement.

Key Points

  • Finasteride blocks DHT production: Finasteride is a 5-alpha reductase inhibitor that prevents testosterone from being converted into dihydrotestosterone (DHT).

  • Targets hair loss and BPH: By lowering DHT levels, finasteride treats male pattern hair loss and benign prostatic hyperplasia (enlarged prostate).

  • Effects are not immediate: It can take 3 to 6 months to see initial results for hair loss, with more significant improvements occurring over the first 1-2 years.

  • Long-term use is necessary: The beneficial effects of finasteride are only maintained as long as the medication is being taken; hair loss resumes after discontinuation.

  • Side effects are possible but rare: The most common side effects are sexual in nature, such as decreased libido and erectile dysfunction, but are uncommon with the 1 mg dose.

  • FDA warning on topical products: The FDA has warned about risks associated with unapproved compounded topical finasteride, which can still cause systemic side effects.

In This Article

What is Finasteride and How It Acts as a DHT Blocker

Finasteride is a prescription medication that belongs to a class of drugs known as 5-alpha reductase inhibitors (5-ARIs). It is primarily used to treat two hormone-related conditions in men: male pattern hair loss (androgenetic alopecia) and benign prostatic hyperplasia (BPH). The core of its function lies in its ability to interfere with the production of dihydrotestosterone, or DHT.

The body's enzyme, 5-alpha reductase, is responsible for converting testosterone into DHT. Finasteride works by binding to and inhibiting this enzyme, effectively blocking the conversion process. There are two types of 5-alpha reductase enzymes: Type I and Type II. Finasteride is a specific and competitive inhibitor of the Type II isozyme, which is primarily found in the prostate, hair follicles, and seminal vesicles. By blocking the Type II enzyme, finasteride significantly reduces DHT levels in the scalp and serum, which is how it mitigates its effects on hair follicles and prostate size.

The Role of DHT in Androgenetic Alopecia and BPH

Dihydrotestosterone plays a crucial role in both male pattern hair loss and the non-cancerous enlargement of the prostate. In hair follicles, DHT attaches to receptors and causes them to shrink over time, a process known as miniaturization. This leads to a shortened hair growth cycle, resulting in thinner, shorter hair strands until the follicles eventually stop producing visible hair altogether. By reducing the amount of DHT reaching these follicles, finasteride helps to reverse this process and restore normal hair growth.

For benign prostatic hyperplasia (BPH), DHT is a key driver of prostate growth. An enlarged prostate can press on the bladder and urethra, leading to urinary symptoms such as frequent urination, weak stream, and difficulty starting urination. By blocking DHT production, finasteride can help shrink the prostate gland over time, alleviating these symptoms. The two conditions are treated with different doses of finasteride; 1 mg daily for hair loss (brand name Propecia) and 5 mg daily for BPH (brand name Proscar).

Effectiveness and Timeline for Results

Finasteride's effectiveness for hair loss is well-documented in clinical studies. For example, some studies found that men using finasteride for hair loss saw significant improvements in hair count and overall appearance after one to two years. However, it is a long-term commitment, as the hair-preserving effects only last as long as the medication is taken. Once treatment is stopped, DHT levels return to normal, and hair loss will likely resume within about a year.

Here is a typical timeline for finasteride results:

  1. Months 1-3: Finasteride begins to work internally by lowering DHT levels, though visible changes are not yet noticeable. It's crucial to continue treatment during this phase even without visible results.
  2. Months 3-6: Initial results may appear, such as a noticeable slowing or halt in hair loss. Some may start to see slight hair regrowth.
  3. Months 6-12: Significant hair growth is often observed, with many experiencing a noticeable increase in hair thickness and density.
  4. Beyond 12 months: Further improvements continue, with some studies showing peak results within the first two years of use.

Finasteride vs. Dutasteride: A Comparison

Another medication in the same class as finasteride is dutasteride (brand name Avodart). While both are DHT blockers, there are key differences in their mechanism and use. Dutasteride inhibits both Type I and Type II 5-alpha reductase, making it a more potent DHT suppressor than finasteride, which only blocks the Type II enzyme.

Feature Finasteride (Propecia) Dutasteride (Avodart)
FDA Approval (Hair Loss) Yes (1 mg daily) Not FDA-approved, often prescribed off-label (0.5 mg daily)
Enzyme Inhibition Primarily Type II 5-alpha reductase Both Type I and Type II 5-alpha reductase
Potency Less potent at lowering DHT More potent, leading to a greater reduction in serum DHT
Effectiveness (Hair Loss) Proven to slow and reverse hair loss Possibly more effective for advanced hair loss due to higher potency
Side Effects Similar risk profile, but possibly lower than dutasteride due to lower potency Similar risk profile, possibly higher risk of sexual side effects due to higher potency

Potential Side Effects and Safety Considerations

While generally well-tolerated, finasteride does carry potential side effects. The most common are sexual in nature and can include:

  • Decreased libido
  • Erectile dysfunction
  • Reduced ejaculatory volume
  • Gynecomastia (enlarged or tender breasts)

It is important to note that these side effects are relatively rare, especially at the 1 mg dose used for hair loss. The risk may increase with the higher 5 mg dose used for BPH and with age. A controversial and rare phenomenon known as "post-finasteride syndrome" (PFS) has been reported, where some men claim persistent sexual and psychological symptoms even after discontinuing the drug. However, the existence and prevalence of PFS are still debated within the medical community.

Pregnant women should not handle crushed or broken finasteride tablets, as absorption through the skin could pose a risk to a male fetus. The FDA has also issued warnings regarding potential risks associated with compounded topical finasteride products, as they are not FDA-approved and carry the same systemic side effects as oral versions. Learn more about the FDA's stance on this issue by reading their alert: FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products.

Conclusion

In summary, finasteride is unequivocally a DHT blocker, functioning as a 5-alpha reductase inhibitor to prevent the conversion of testosterone into dihydrotestosterone. Its mechanism of action directly addresses one of the primary hormonal causes of male pattern hair loss and benign prostatic hyperplasia. While effective, finasteride requires consistent, long-term use to maintain its benefits, and potential side effects, though rare, should be discussed with a healthcare provider. The choice between finasteride and other treatments, like the more potent dutasteride, depends on individual needs and a thorough medical consultation.

Frequently Asked Questions

Finasteride blocks DHT by inhibiting the enzyme 5-alpha reductase, which is responsible for converting the hormone testosterone into DHT. By blocking this conversion, finasteride lowers the amount of DHT in the body.

While finasteride starts lowering DHT levels almost immediately, it typically takes 3 to 6 months to see the first visible signs of reduced hair loss or regrowth. Full effects may take 12 months or longer.

Yes, to maintain the hair-preserving and regrowth effects, you must continue taking finasteride daily. If you stop, DHT levels will return to normal, and any regrown hair will likely be lost within a year.

The most common side effects, though rare with the 1 mg dose for hair loss, include decreased libido, erectile dysfunction, decreased ejaculate volume, and breast tenderness or enlargement.

No, finasteride is not approved for use in women, especially those who are pregnant or may become pregnant. It can cause birth defects in male babies if absorbed.

The primary difference is the dosage. Finasteride is prescribed at 1 mg daily for hair loss (Propecia) and 5 mg daily for benign prostatic hyperplasia (Proscar).

Finasteride does not significantly lower testosterone. In fact, by preventing its conversion to DHT, it can cause a modest increase in testosterone levels, though this increase is generally not a concern.

The FDA has warned that unapproved compounded topical finasteride can still be absorbed systemically and cause the same side effects as the oral version, potentially exposing others to the medication as well. There is no FDA-approved topical formulation.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.